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Abstract
Background: The special physicochemical properties of gold nanoprisms make them very useful for biomedical
applications including biosensing and cancer therapy. However, it is not clear how gold nanoprisms may affect
cellular physiology including viability and other critical functions. We report a multiparametric investigation on the
impact of gold-nanoprisms on mice and human, transformed and primary cells as well as tissue distribution and
toxicity in vivo after parental injection.
Methods: Cellular uptake of the gold-nanoprisms (NPRs) and the most crucial parameters of cell fitness such as
generation of reactive oxygen species (ROS), mitochondria membrane potential, cell morphology and apoptosis were
systematically assayed in cells. Organ distribution and toxicity including inflammatory response were analysed in vivo in
mice at 3 days or 4 months after parental administration.
Results: Internalized gold-nanoprisms have a significant impact in cell morphology, mitochondrial function and ROS
production, which however do not affect the potential of cells to proliferate and form colonies. In vivo NPRs were only
detected in spleen and liver at 3 days and 4 months after administration, which correlated with some changes in tissue
architecture. However, the main serum biochemical markers of organ damage and inflammation (TNFα and IFNγ)
remained unaltered even after 4 months. In addition, animals did not show any macroscopic sign of toxicity
and remained healthy during all the study period.
Conclusion: Our data indicate that these gold-nanoprisms are neither cytotoxic nor cytostatic in transformed
and primary cells, and suggest that extensive parameters should be analysed in different cell types to draw
useful conclusions on nanomaterials safety. Moreover, although there is a tendency for the NPRs to accumulate in liver
and spleen, there is no observable negative impact on animal health.
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Background
The intrinsic optical properties of metal nanoparticles
render them as versatile tools for a variety of bioapplica-
tions including, but not limited to, imaging, therapy and
diagnosis [1–4]. In particular, anisotropic gold nanopar-
ticles (NPs) such as nanorods [5], nanoshells [6], or
nanoprisms [7, 8] show great promise for in vivo appli-
cations [5, 9–12]. Three main facts support the use of
anisotropic gold NPs. First, the optical activity of these
materials can be tuned along the NIR range, in the so-
called biological window where absorption by physio-
logical components is less restrictive [13]. Second, in
contrast to other metal NPs made of silver or copper,
gold is more noble and is considered one of the biologic-
ally safest element [11]. And finally, the abundance of syn-
thetic approaches currently available offers researchers
the possibility of engineering the size, shape and sur-
face of these materials, enabling tailoring for specific
purposes [11, 14].
In parallel to investigations concerning the development
of new nanomaterials with optimal bio-performance (i.e.
stability and performance for working in complex
biological scenarios), testing the interactions of these ma-
terials with the living world has become a major issue for
the successful development of bio-nanotechnology
[12, 15]. Past, present and future data concerning the
impact of nanomaterials on biological systems will
greatly influence the future roadmap of nanomaterials
for bioapplications [16]. Materials aimed for bioappli-
cations should preserve their original physicochemical
properties in physiological conditions, but should also
avoid impairing or compromising the proper function
of biological entities such as proteins and cells. Nano-
toxicology is a rapidly growing area, which is devoted
to investigate such nano-bio interactions [17, 18].
Typically, the physicochemical properties of NPs in-
cluding composition (inorganic core and surface coat-
ing), size, shape, crystallinity, and hydrophobicity can
be correlated with their toxicity in vitro, which how-
ever can also vary among distinct cell lines and/or
dose [14]. Yet no matter which NP model is being
assayed, there are some common adverse effects [19]
which can be triggered by the intrinsic dimensions of
the NP under study [20]. Upon exposure to NPs the
most common cellular response involves the gener-
ation of ROS, which can be tolerated up to certain
levels without side effects, typically depending on the
cell type [19, 21]. In addition, alteration of the cellu-
lar homeostasis due to massive accumulation of NPs
inside cells or interaction with signalling pathways
can lead to a multitude of adverse effects [19, 22]. It
therefore stands to reason that choosing the most ap-
propriate components and dose might prevent to
some extent an adverse impact on cells. Toxicity
issues triggered by release of toxic ions from metallic
NPs composed of Ag [23] and Cu, or QDs containing
Cd, are well documented in the literature [14]. In
contrast, gold NPs coated with densely packed thiolated
chains of polyethylene glycol (PEG), as used here, are be-
lieved to be among the safest NPs [24, 25].
Regarding near infrared (NIR) -active plasmonic mate-
rials, the toxicity of gold nanorods and nanoshells has
been widely studied in vitro and in vivo and photother-
mal therapy using these materials is already in phase 1
clinical trials for the treatment of different cancer types
(see details for AuroLase® Therapy) [26]. In contrast, the
impact of gold NPRs on cell cultures has yet to be inves-
tigated or characterized in detail, a prerequisite before
analysing its safety and potential applications in in vivo
models. The molar extinction coefficient of gold NPRs
can be considerably larger to those of nanorods or nano-
shells, [27] and therefore the interaction with incident
light can be more efficient, leading to positive effects for
various bioapplications such as photothermal therapy
[7, 8], optoacoustic imaging [28], or plasmonic driven
thermal biosensing [13, 29].
We have recently used different types of NPs to ana-
lyse the influence of shape on the interaction between
NPs and cells and provide preliminary data on the po-
tential toxic effects in vitro [20]. As a continuation of
that work here we have focused on gold NPRs to per-
form a more extensive and detailed study of its effect on
several common cellular parameters including ROS gen-
eration, mitochondria membrane potential, proliferation,
cell morphology and apoptosis, employing a variety of
cell models and two primary cell lines. Moreover, we
have monitored tissue distribution and the main serum
biomarkers of organ damage and inflammatory response
in a mouse model in vivo in order to analyze the poten-
tial adverse effects of employing NPRs as carriers in
theragnostic applications.
Results
Characterization of NPRs
NPRs are thin (ca. 10 nm), flat single crystals, which
present three congruent edge lengths of ca. 150 nm
(Additional file 1: Figure S1). The surface of the NPRs
was saturated with heterofunctional PEG chains (thiol-
PEG-carboxy, 5 kDa). PEGylation was achieved by using
heterofunctional PEG chains (HS-PEG-COOH), which
bind covalently to the gold surface through its thiol
group. The carboxylic end group was used for further
surface functionalization with 4-aminophenyl-β-D-gluco-
pyranoside and/or a fluorescence reporter, 5-TAMRA
cadaverine (an amine-modified rhodamine) using a
carbodiimide crosslinker (more details in the materials sec-
tion) (Additional file 1: Figure S2 and S3). Functionalization
of NPs with glucose enhances both selectivity and uptake
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by target cells [20]. The rhodamine dye, TAMRA, was used
as a fluorescent marker to facilitate the localization of the
NPRs within cells by confocal microscopy. ζ–potential
measurements and the different electrophoretical mobility
among the differently-modified NPRs confirmed success-
ful NPR modifications. Additionally, fluorescence spec-
troscopy measurements confirmed that NPRs were
susscessfully modified with TAMRA (see Additional file 1:
Figure S2-S3). Finally, the colloidal stability of the NPRs
was evaluated incubating a suspension of NPRs in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS), 1% L-
glutamine, and 1% penicillin/streptomycin during
24 h at room temperature. Then, the UV-vis spectra
of the NPRs was measured and compared with the
spectra before incubation in cell media. This test
proved that the NPRs retain their colloidal stability in
the conditions used for the cell studies with no sign
of aggregation (see Additional file 1: Figure S4). Four
NPR models were incubated with the cells: PEGylated
NPRs (NPR-P), PEGylated NPRs modified with rhoda-
mine only (NPR-PT), glucose (NPR-PG), and both
molecules (NPR-PTG).
Internalization of NPRs by cells
We chose six common cell lines, i.e. three from human
(A549: adenocarcinoma alveolar basal epithelial cells;
MiaPaca: pancreatic carcinoma cells; and HeLa: cervical
cancer cells) and three from mouse (MEF-SV40: embry-
onic fibroblasts immortalized with the virus SV40; B16:
melanoma cells; and MC57G: fibrosarcoma cells).
Several key factors brought us to select these cells from
other common cell models. In the first instance, since
we plan to test the effect of NPRs in a mouse model in
vivo, the use of mouse cells in vitro is very useful to help
to understand the upcoming in vivo results. Further, re-
sults in the mouse model require validation in a human
system, the end potential target of this technology. In
addition, since the grand aim of this research is to use
NPRs as photothermal probes for cancer treatment and
tumoral cell lines were chosen as the primary targets.
Also, MEF-sv40 cells were chosen as a model of fibro-
blast non-tumoral cells since although they are immorta-
lised, they are not tumorigeneic and thus they are
usually used as a model of primary-like fibroblast cells.
Lastly, as genuine primary cells, we used some of the
main cell types interacting with and potentially respond-
ing against NPs after in vivo parental administration,
peripheral blood mononuclear cells (PBMCs) and mac-
rophages, the cells involved in the clearance of exogen-
ous materials.
First, the uptake of the different types of NPs was ana-
lysed in the target cells in order to ensure that NPs inter-
act and are internalized by those cell types. Accordingly,
NPRs were added to the cells at gold concentrations ran-
ging from 25 to 200 μg/mL, commensurate with values
typically used in similar studies [22]. The change in side-
scattered light (SSC) was analysed by flow cytometry,
which is proportional to cell morphology (granularity and
intracellular complexity). As shown in Additional file 1:
Figure S5 there was an increase in the SSC of the cells in-
cubated with all types of NPRs, and this change was
particularly pronounced in the case of NPRs containing
glucose indicating that cells changed their intracellular
morphology after interaction with NPRs, a change that
could be related to NPR uptake. The results of fluores-
cence confocal microscopy shown in Fig. 1 at two repre-
sentative concentrations (100 and 200 μg/mL), confirm
that NPRs were readily internalized and accumulated
inside the cells. As expected, the level of internalization
varied from one cell type to another, likely due to the in-
trinsic endocytic properties of each cell type. Independ-
ently of the differences in the NPRs uptake between
various cell types, the influence of surface coating on the
internalization can be clearly observed in Fig. 1. NPR-PT
probes were only poorly internalized by almost all of the
cells lines, whereas coating with glucose (NPR-PTG
probes) highly increased the level of internalization in all
cell lines, even when the concentration of NPR-PT was
doubled (200 μg/mL) in comparison with NPR-PTG.
NPR-PT probes are labelled with the dye, but in terms of
surface coating they are covered by a densely packed PEG
coating, which, as shown in Fig. 1, prevents cell up-
take, in agreement with previous results [20, 30].
ROS generation by cells upon interaction with NPs
ROS generation was investigated in all of the cell lines
after 48 h of incubation, using increasing concentrations
of two NPR probes (dye labelled probes were excluded
because of fluorescence interference with the test). There
are several fluorogenic probes commonly employed for se-
lective detection of ROS such as O−2 , mitochondrial O
−
2 ,
H2O2 or ONOO
−. However, the reliability and feasibility
of these tests for detection and quantification of intracel-
lular ROS have been questioned [31, 32]. In the context of
ROS generation triggered by the interaction of NPRs with
cells, they are however widely employed. Here, we used
dihydroethidine (2HE) for “catching” intracellular O2
- ,
enabling for qualitative detection of the fluorescence
product 2-hydroxyethidium (2-OH-E+). We decided to
analyse the superoxide anion since this is the first
and most abundant oxygen radical generated during
the physiology and pathophysiology of ROS.
As shown in Fig. 2a, after 48 h of NPR incubation with
the cells, the impact of NPR-PG in terms of ROS produc-
tion is apparent in half of the cell lines (MEF, MC57G and
HeLa cells). However, increasing concentrations of NPR-P
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induce ROS generation only in MEF cells. The level of
ROS generation also depends on the cell type. To be no-
ticed, A549 cells, a highly resistant tumoral cell line widely
used for in vitro toxicity studies, show the lowest ROS
levels. However they presented a level of NPR internaliza-
tion similar to the one observed in MEF and HeLa cells,
which showed the highest ROS production. The cytotoxic
drug staurosporine increases ROS in half of the cell lines
although as in the case of NPRs at different levels, indicat-
ing that ROS production depends on the cell line. Again,
these results provide crucial evidence on the importance
of using several cell models to properly interpret the
results employing NPs.
Mitochondrial damage: Loss of mitochondrial membrane
potential
ROS generation is mostly a consequence of uncoupled
electron mitochondrial transport and usually it is ac-
companied by a loss of mitochondrial membrane poten-
tial. In order to investigate the possible mitochondrial
damage caused by NPRs, cells were supplemented with
increasing concentrations of NPR-P or NPR-PG.
Figure 2b shows the important impact of increasing con-
centrations of NPRs on the mitochondrial membrane
potential (ΔΨm). Although there are differences between
the cell lines concerning the loss of ΔΨm, the concentra-
tion and functionalization effect is apparent. However, it
Fig. 1 Analysis of nanoparticles internalized within cells using confocal microscopy. The indicated cells were incubated with NPR-PT and NPR-PTG
nanoparticles at four different concentrations (25, 50, 100 and 200 μg/mL) for 24 h and were fixed with 4% PFA and dyed with Hoechst 3342 (DNA),
pictures were taken using a confocal microscope as indicated in experimental section. A representative experiment 200 μg/mL of NPR-PT and 100 μg/mL
of NPR-PTG is shown. Scale bar: 30 μm
Pérez-Hernández et al. Particle and Fibre Toxicology  (2017) 14:41 Page 4 of 20
should be stressed that, when ROS and ΔΨm data are
directly compared for each cell line, there are clear dif-
ferences between them. For example, loss of ΔΨm corre-
lates with ROS generation in HeLa, MEF, MC57G and
B16 cells; yet the impact of NPR internalization on ROS
generation and loss of ΔΨm is more evident in HeLa and
MC57G cells than in B16 cells. In contrast, loss of ΔΨm
does not correlate with ROS generation in A549 cells.
Therefore, although the generation of ROS and loss of
ΔΨm correlate with NPR concentration (in particular for
glucose-modified NPRs), different cell lines respond dif-
ferently. TAMRA seemed to have an effect on the loss of
ΔΨm and thus the impact of glucose was difficult to as-
sess in TAMRA functionalized NPR (data not shown).
Again staurosporine induced loss of ΔΨm in all cases ex-
cept for MC57G cells.
Apoptosis and NPRs
To analyse apoptosis we monitored phosphatydylserine
(PS) translocation and membrane damage by flow cy-
tometry using annexin-V and 7-AAD double staining,
which allowed us to distinguish between early apoptotic
cells (annexinV+/7AAD– cells) and late apoptotic/nec-
rotic cells (annexinV+/7AAD+ cells). As shown in Fig. 3,
Fig. 2 Analysis of the effect of NPRs on ROS production and loss of mitochondrial membrane potential by flow cytometry. Analysis of the
superoxide anion generation by flow cytometry. The indicated cells were mock treated (ctrl) or incubated with NPR-P and NPR-PG nanoparticles
at four different concentrations (25, 50, 100 and 200 μg/mL) for 48 h. (a) Superoxide generation was monitored using 2HE and (b) ΔΨm was mon-
itored using DIOC6 as indicated in experimental section. As positive control (C+) staurosporine 1 μM was used. Data represent mean values ± SD
from three independent experiments *p < 0.05, **p < 0.01, ***p < 0.001
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neither apoptosis nor necrosis was observed in any
cell type for any of the NPR derivatives. Staurosporine
induced PS translocation in most of the cell lines al-
though at different extent. Although Annexin-V stain-
ing did not reach statistically significant difference in
HeLa and B16 cells, a clear annexin-V positive cell
population could be detected in the dot plots (Fig. 3b) in
both cell lines indicating delayed cell death in these cell
lines (see Fig. 4).
Cell proliferation: Clonogenic studies
Finally, to certainly confirm that NPRs did not affect cell
viability in vitro, we analysed the effect of NPRs on the
ability of the different cell lines to grow and form col-
onies 10 days after incubation, an assay that is consid-
ered as the gold standard to assess cell viability. As
shown in Fig. 4, MEF, MiaPaca, HeLa, B16 and A549
cells incubated with the highest concentration of the
four NPRs probes form the same number of colonies as
Fig. 3 Analysis of phosphatidilserine (PS) translocation and membrane permeabilisation by flow cytometry. The indicated cells were mock treated
(ctrl) or incubated with four types of nanoparticles (NPR-P, NPR-PG, NPR-PT, NPR-PTG) at four different concentrations (25, 50, 100 and 200 μg/mL)
for 48 h and PS translocation and membrane permeabilisation were monitored using annexin-V and 7AAD respectively as indicated in experimental
section. As positive control (C+) staurosporin 1 μM was used. (a) Data represent mean values ± SD from three independent experiments. *p < 0.05,
**p < 0.01, ***p < 0.001. (b). A representative experiment is shown at the concentration of 100 μg/mL. Numbers correspond to the percentage of
cells in each quadrant
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the controls. Consequently cell growth and capability of
forming colonies (cell viability) are two crucial factors
that are not influenced by the incubation of cells with
any of the four NPR probes. In contrast, cells incu-
bated with staurosporine showed low proliferation
rates in all cell lines, despite the different sensitivity
in terms of ROS production and loss of ΔΨm ob-
served between them. These results prove that staur-
osporine is able to induce cell death in all cell lines,
but with a delayed kinetics in B16 and HeLa cells
(compare with Fig. 3a).
This test cannot be applied to all cell lines (MC57G)
because of the intrinsic ability of specific cells to form
colonies; however, this finding undoubtedly confirms
that ROS and mitochondrial changes after NPR expos-
ure are not toxic for the tested cells, including human
and mouse cells of tumoral (HeLa, MiaPaca, A549, B16)
and non-tumoral (MEF) origin.
Primary cells: Macrophages and PBMCs
The experiments performed above indicate that gold
NPRs are neither cytotoxic nor cytostatic for transformed
Fig. 4 Analysis of the effect of NPRs on cell survival using a clonogenic assay. The indicated cells were mock treated (ctrl) or incubated with four
types of nanoparticles (NPR-P, NPR-PG, NPR-PT, NPR-PTG) at four different concentrations (25, 50, 100 and 200 μg/mL) for 48 h. Subsequently, 100
cells were seeded per well by triplicates and incubated in fresh medium for 10 days. After that, cells were stained with Crystal Violet and colonies
were counted as described in experimental section. As positive control (C+) staurosporine 1 μM was used. (a) Survival was calculated as percent-
age of colonies growing referred to the number of colonies in the negative control. Data represent mean values ± SD from three independent experi-
ments. *p < 0.05, **p < 0.01, ***p < 0.001. (b) Pictures from single wells of a representative experiment (100 μg/mL) are shown
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cells. However this does not necessarily mean that they
would not present toxicity in the context of a physiological
setting where they encounter with “healthy” cells. To this
goal the uptake in primary cells was assayed using the
same protocols as in the immortalized cell lines. We chose
cells from the immune system (blood lymphocytes and
differentiated macrophages) since they are the first ones
encountered by NPs when administered in vivo. In the
case of bone marrow derived macrophages that presented
a inflammatory M1 phenotype (see methods), confocal
microscopy confirmed internalization of both NPR-PT
and NPR-PTG probes (Fig. 5a). Analysis of ROS gener-
ation and loss of ΔΨm suggested that both processes were
induced by all types of NPRs (data not shown).
Unfortunately a detailed and reliable quantification of
those processes was not possible due to the high level of
intrinsic autofluorescence of the macrophages, which is
quenched by NPRs. Despite this technical problem, deter-
mination of PS translocation (annexin V) and membrane
permeabilisation (7AAD) (Fig. 5b) indicated that NPRs are
not toxic to the macrophages. Although staurosporine
was not able to kill the macrophages as analysed by the
annexin V staining, this was not due to an inherent inabil-
ity to translocate PS since other stimuli like cytotoxic T
cells or bacterial infection induced PS translocation in this
cell type correlating with loss of cell viability (data not
shown and [33]).
In contrast to macrophages and immortalised cell
lines, confocal microscopy pictures show that the NPR-
PT and NPR-PTG probes displayed a poor internaliza-
tion by human blood lymphocytes (PBMCs) (Fig. 5c).
ΔΨm and ROS generation were less affected than in cell
lines, likely due to the lower internalization rate ob-
served here (Fig. 5d and e) and, again, PS translocation
and membrane permeabilisation were absent (Fig. 5f ),
indicating that NPRs were neither toxic for lymphocytes.
In vivo toxicity studies
Intravenous administration of 6 μg/g NPR-PTG did not
affect animal body weight 72 h or 4 months after admin-
istration (Fig. 6a and c). Neither other signs of toxicity
or animal distress such as disheveled hair, irregular res-
piration, gastrointestinal symptoms, immobility or death
were observed. After extracting the main organs, differ-
ences in organ index were not detected, except for kid-
neys 72 h after the NPs injection, which appeared bigger
when compared to those of control mice (Fig. 6b). There
were no observable differences in organ indexes four
months after injection (Fig. 6d). Among four blood bio-
chemical parameters of systemic or specific organ dam-
age (ALT –liver-, CK –muscle-, creatinine –kidney- and
LDH –any tissue/cell-) and two main inflammatory cyto-
kines (IFNγ and TNFα as markers of innate and adapta-
tive inflammatory responses) that were analyzed no
significant variations were found, indicating that NPRs
did not induce any detectable tissue or cell damage, in-
cluding inflammatory response (Fig. 7).
Next we analysed tissue sections by haematoxylin/
eosin (HE) staining to search for structural changes or
apparent histopathological abnormalities. After 72 h no
significant changes were found, in any of the analyzed
tissues including liver, spleen, kidney, heart, lung, thy-
mus and reproductive organs. In turn, four months later,
hepatocytes were enlarged and displayed a high number
of vacuoles in their cytoplasm (Fig. 8). These changes
appeared more frequently in the central lobular section,
being compatible with a hydropic change or vacuolar
degeneration. The presence of glucogen deposits was
discarded as analysed employing a glucogen specific dye
(Additional file 1: Figure S6). Also, the presence of
Kupffer cells with an enlarged cytoplasm was observed.
These cells contained a black pigment that could be
compatible with the presence of NPR-PTG (Fig. 8c).
Although the white pulp of the spleen was hypertrofic,
the architecture of the organ was not altered in a consid-
erable way (Fig. 9b). Macrophages with a black pigment
in the cytoplasm (compatible with the NPR-PTG) were
identified in the white pulp (Fig. 9c and d).
Biodistribution of the NPRs in vivo
Fluorescence microscope studies were carried out to de-
termine if the NPRs bearing a fluorophore were present
in the tissue sections of the main organs, i.e. liver,
spleen, kidneys, heart, lungs, thymus and reproductive
organs. 72 h after the intravenous injection it was not
possible to find in any trace of a fluorescence signal in
these organs; but it was identified in the urine collected
24 h after injection. Importantly however, the ICP-MS
analysis did not detect gold in urine (data not shown)
thereby suggesting that the fluorophore was detached
from NPRs, which is in accordance with previous work
[34]. Thus, to corroborate the biodistribution of the
NPRs, ICP-MS of the organs was carried out. 72 h after
treatment NPRs were found in the spleen and liver, ap-
proximately 0.4 μg Au per mg of lyophilized organ. The
amount of NPRs found in the liver corresponded to 25%
of the total amount of NPRs originally injected; whereas
the spleen contained just 5%. No NPRs were detected in
other organs or in the urine (Fig. 10). Note that the
organs that were collected are the ones that more fre-
quently accumulate NPs (spleen, liver, lungs) and other
organs essential for other vital functions, such as the re-
productive organs and thymus were also collected. The
remaining NPRs might therefore be contained in other
areas not collected, such as the intestines and canvas or
be excreted in the faeces.
Four months after the injection, NPR-PTG were still
present in liver and spleen. While in the liver the NPs
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amount was reduced to 10–15% of the injected dose,
in the spleen this amount remained similar to that of
72 h post injection (3–5%) suggesting that the liver
was somehow able to degrade at least in part the
NPR-PTG.
To confirm the presence of the NPR-PTG in the
spleen and liver four months after injection, TEM and
STEM along with EDX were performed (Fig. 11). As ex-
pected, NPR-PTG were found in macrophages, however,
the shape of the NPR-PTG in the liver was different
Fig. 5 Analysis of the effect of nanoparticles on the viability of mouse primary macrophages and human PBMCs. Mouse bone marrow derived
macrophages and human PBMCs were mock treated (ctrl) or incubated with four types of nanoparticles (NPR-P, NPR-PG, NPR-PT, NPR-PTG) at four con-
centrations (25, 50, 100 and 200 μg/mL) for 24 h as indicated in experimental section. (a) Analysis of nanoparticles entry in macrophages using confocal
microscopy. A representative experiment 100 μg/mL of NPR-PTG and 200 μg/mL of NPR-PT is shown. (b) Detection of phosphatydylserine transloca-
tion (AnnexinV) and cell membrane permeabilisation (7AAD) in macrophages by flow citometry. (c). Analysis of nanoparticles entry in PBMCs using
confocal microscopy. A representative experiment 100 μg/mL of NPR-PTG and 200 μg/mL of NPR-PT is shown. (d). Analysis of ΔΨm loss (DIOC6), (e) de-
tection of superoxide anion generation and (f) detection of phosphatydylserine translocation (AnnexinV) and cell membrane permeabilisation
(7AAD) in PBMCs by flow citometry. Data represent mean values ± SD from three independent experiments. *p < 0.05, **p < 0.01,
***p < 0.001. As positive control (C+) staurosporine 1 μM for macrophages and cladribine 5 μM for PBMCs was used. Scale bar: 30 μm
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from that of the original NPR, which can be related to a
digestion process.
Discussion
Toxicity is a major concern that needs to be carefully
addressed before a new nanomaterial can be considered
to be translated into in vivo biomedical clinical applica-
tion. Moreover, it should be tested at different levels in-
cluding cell uptake and pharmacokinetics [35], immune/
inflammatory responses [36], genotoxic effects or cell
death. The overall aim of this work was to investigate
the toxicity of anisotropic gold nanoprisms (NPRs) and
the influence of the surface coating, focusing on a de-
tailed analyses of its impact on oxidative stress and cell
death in vitro as well as toxicity and biodistribution in
vivo. To this aim we have employed in vitro cell models
and validated the results in vivo in mice. We used
sulphate-capped NPRs with ca. 150 nm in length and
10 nm thicknesses (see Additional file 1: Figure S1)
modified with PEG. PEG molecules are considered to be
among the most efficient antifouling agents used for sta-
bilizing NPs for bioapplications; especially the high mo-
lecular weight derivatives such as the 5 kDa chain used
in this study [37]. Confirming it, all tests performed on
the final modified NPRs proved that the NPRs retain
their colloidal stability in the conditions used for the cell
studies (see Additional file 1: Figure S4).
We show that cellular internalization of NPRs varies
for different cell lines, which may be explained by the
various different intrinsic phagocytic properties and/or
levels of glucose requirement. Upon confirming the in-
ternalization of NPRs by all cell lines, the possible toxic
effects induced on those cell types were examined. The
pioneering work of Nel and co-workers has established
ROS generation as among one of the most common
effects caused by internalized NPs [17], although it re-
mains unclear precisely which properties of NPs contrib-
ute to the ROS induction. Several studies have focused
on surface characteristics, size, shape and other
parameters related to increased cytotoxicity by ROS
production [20, 38, 39]. A recent study performed on
differently functionalized gold and silver NPs highlights
also the importance of the components of cell culture
medium like serum protein, which upon adsorbtion onto
the NPs surface (so-called protein corona) may change
the surface charge of NPs and therefore affect their abil-
ity to produce ROS [40].
Our results regarding ROS generation indicate that the
association of cells with NPRs induced ROS generation
in half of the cell lines tested, which was accompanied by
loss of ΔΨm in some cases. Intracellular ROS accumula-
tion can trigger diverse modalities of cell death including
apoptosis and necrosis [41]. In line with our findings
Soenen et al. found ROS generation and loss of ΔΨm in
Fig. 6 Analysis of (a and c) the weight gain of mice treated with nanoparticles and (b and d) the relative weight of the organs after treatment.
Data of (a and b) 3 days and (c and d) 4 months after treatment. Mice were injected (i.v) with 6 μg/g NPR-PTG (green) or the same volume of
PBS in the group control (black). The mice weight was measured (a) before and after 3 days of the treatment and (c) weekly during the following
4 months. (b) and (d) the mice were sacrificed and the weight of the different organs were measured after treatment and referred to the mice
weight. Data represent mean values ± SD from 5 mice. *p < 0.05
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a multiparametric study with polymer coated gold NPs
of 4 nm in diameter and at concentrations above
100 nM (concentration of gold ca. 40 μg/mL) [22]. How-
ever in this case, internalization of those NPs caused
DNA damage and cell cytotoxicity. Loss of ΔΨm and
cytotoxicity were prevented by using a ROS scavenger.
In contrast to these findings a recent work has
highlighted the role of mitochondrial depolarization in
tumoral cells, following uptake of positively charged gold
NPs as a defense mechanism for counteracting the in-
creased levels of cytosolic Ca2+ induced by NP uptake
[42]. In line with these findings we show that ROS gen-
eration and mitochondrial perturbation are not sufficient
to cause apoptosis even in primary cells. Remarkably,
NPRs do not induce apoptotic or necrotic features even
in cells where the ΔΨm was down-regulated. In contrast,
loss of ΔΨm and/or ROS generation induced by stauros-
porine (or other stimuli like cytotoxic T cells or bacterial
infection in the case where staurosporine is not effective
–data not shown-) were accompanied by induction of
phosphatidylserine (PS) translocation and membrane
permeabilisation and lower number of colony formation,
indicating that lack of pro-apoptotic markers during in-
cubation with NPRs was not due to a general defect in
the cells used. Here, it should be noted there are differ-
ent ways to down-regulate ΔΨm and not all of them lead
to the loss of cell viability. One of them is the formation of
a permeability transition pore (PTP) that involves
Fig. 7 Analysis of four blood biochemical parameters of systemic or specific organ damage (ALT –liver-, CK –muscle-, creatinine –kidney- and
LDH –any tissue/cell-) and two main inflammatory cytokines (TNFα and IFNγ). Mice were injected (i.v) with 6 μg/g NPR-PTG (green) or the same
volume of PBS (black) in the group control. The mice were sacrificed after four months and the blood was collected by cardiac punction as indi-
cated in experimental section. Dots represent values from each mouse and bars ± SD
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both inner and outer mitochondrial membranes. Its for-
mation is reversible and regulated by intracellular Ca2+
and ROS. If cells are able to reduce the levels of ROS
and Ca2+, the pore is closed and the mitochondrion re-
covers its function. On the contrary, the permanent
opening causes mitochondrial rupture by osmotic shock,
triggering cell death [43]. This could help to explain ap-
parent contradictory results observed in different stud-
ies. Thus, a reliable measure of toxicity based on ROS
production and loss of ΔΨm will be dependent on the
intensity of the stimulus and the ability of the cell to
counteract the effect of NPs uptake. Supporting this
Fig. 8 Hematoxylin-Eosin stain of the liver of mice treated with NPRs. Mice were injected (i.v) with (b-d) 6 μg/g NPR-PTG or the same volume of
PBS in the (a) group control. The mice were sacrificed after four months and organs were fixed and processed for the H&E stain, as indicated in
experimental section. Representative images are shown
Fig. 9 Hematoxylin-Eosin stain of the spleen of mice treated with nanoparticles. Mice were injected (i.v) with (b-d) 6 μg/g NPR-PG or the same
volume of PBS in the (a) group control. The mice were sacrificed after 4 months and the organs were fixed and processed for the H&E stain, as indicated
in experimental section. Representative images are shown
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hypothesis, we have recently shown that the production
of high levels of ROS and mitochondrial depolarisation
during photothermal therapy using gold NPRs irrevers-
ibly lead to cell death [8].
Our data clearly indicate that internalization of NPRs
induces signs of cell damage like ROS generation and
mitochondrial depolarisation in some cell lines; yet those
effects are not sufficient to compromise cell viability as
confirmed using clonogeneic assay, the gold standard for
analysing cell toxicity. In contrast to the widely used MTT
test that only indicates the proliferation status of the cells,
a clonogeneic assay tests the ability of single cells to form
colonies 10 days after exposure to a specific stimulus [44].
In our case, these assays indicated that NPRs do not affect
cell viability at any level including DNA damage or cell
cycle arrest. Additionally, this finding indicates that to
really assess cellular toxicity of NPs employing in vitro
models, several cell types of different origin should be
tested using a combination of different assays.
All these results employing transformed cells were
confirmed on primary “healthy” cells, such PBMCs and
macrophages. NPRs were internalized by macrophages;
however, due to the phagocytosis capacities of macro-
phages no differences were observed in the internaliza-
tion of different types of NPRs. Mirroring the results
obtained with immortalized cell lines, the viability of the
macrophages was not compromised. In contrast to
macrophages and immortalised cell lines, NPRs were
poorly internalized by human PBMCs and thus, ROS
generation and ΔΨm lost were less evident than in the
case of the tumour cell lines. Again, NPRs were neither
toxic for lymphocytes.
Finally, the absence of toxicity in cell models was con-
firmed in vivo, by treating mice with NPR-PTG and test-
ing the main serum biomarkers of tissue damage and
inflammation as well as NP accumulation in organs by
anatomy pathology. Although we found that NPRs were
accumulated in liver and spleen four months after injec-
tion, the animals did not show any sign of mortality or
morbidity and all serum and tissue toxicity markers
remained unaltered, including those reporting a inflam-
matory immune response. These results indicate that ei-
ther in contrast to cell models mitochondrial
perturbations are not happening in vivo or if mitochon-
drial function is also affected in vivo, it is not sufficient
to cause acute or chronic toxicity at least during the
time frame analysed (four months). Several works have
analysed in vivo toxicity of gold nanoparticles with differ-
ent sizes and forms employing different administration
ways [45–48]. A direct comparison with our findings is
difficult since administration route, size and morphology
(rod, sphere, etc) dramatically change in vivo NP behavior
and most of the works have employed gold nano-
spheres. In these studies it was shown that i.v.
Fig. 10 Biodistribution of nanoparticles in vivo. Mice were injected (i.v) with 6 μg/g NPR-PG (green) or the same volume of PBS in the group control
(black). The mice were sacrificed after (a and b) 3 days or (c and d) four months and the organs were lyophilized and processed as indicated in
experimental section, in order to analyse the quantity of gold by ICP-MS. Data represent mean values ± SD from three mice
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administration lead to a liver and spleen accumulation as
found here employing NPRs, while oral administration
lead to kidney accumulation. Subsequently and in line
with our results it was shown that while oral or i.p.
administration of gold nanospheres induced toxic effects
in mice, i.v. injection did not [47]. In a recent study,
24 h after the injection of 2.7 mg/kg PEGylated NPRs
(61.51 ± 2.91 nm) (57 μg per mouse) it was found that the
nanoparticles presented the highest level of accumula-
tion in the spleen, whereas the liver and intestine had
Fig. 11 Electronic microscopy analysis of the nanoparticles in the spleen (a-b) and liver (c-d) of treated mice. Mice were injected (i.v) with 6 μg/g
NPR-PG. Mice were sacrificed after 4 months and the organs were fixed and processed for the TEM (a and c) and STEM (b and d) analysis, as indicated
in experimental section. Representative images are shown
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the next highest concentrations [49]. Moreover, these
PEGylated NPRs did not provoke significant biochem-
ical or hematological differences between untreated
control mice and nanoparticles-treated mice, which is in
accordance to our results.
Gold NPs are traditionally considered inert and thus
resistant to degradation in vivo. However, they can be
slowly dissolved as cells contain thiols (i.e. glutathione)
that can strongly bind to the Au surface, and under cer-
tain conditions pull out gold atoms from the NP surface
using the surface-bound ligands [50, 51]. Supporting this
hypothesis we have observed that although NPR-PTG
were not detected in urine by ICP-MS, the fluorophore
attached to the surface of the NPR was found just after
24 h. This would mean that the ligand was removed
from the NPR once injected and then excreted in the
urine. These results are in accordance to those of
Kreyling et al. who employing different isotopes to se-
lectively label the core and the shell of AuNPs, found
that the Au core was accumulated in the liver, while rest
of the coating appeared in urine [34]. The fluorophore
excretion could also explain the observed difference in
the weight of the kidneys 72 h after injection. Renal
cleareance could produce inflammation increasing the
relative weight of the kidney [52] which in the present
study is a transient effect that could be related with the
fluorophore excretion due to the fact that the kidneys
recovered their usual weight 4 months after injection.
Together, the quantification of Au by ICP-MS and the
results of STEM imaging suggest that liver tissue is able to
slowly degrade and eliminate NPRs. In a recent study with
iron oxide coated Au nanoparticles it was found that after
the dissolution of iron oxide crystals Au particles de-
graded to form progressively smaller particles that tend to
self-assemble together [53]. In a study with 40 nm Au
nanoparticles injected i.v. (4.5·1010 particles/mouse) it was
found that a fraction of gold-loaded cells in the liver grad-
ually decreased to about one fifth after 6 months [54].
Moreover, over time it was found that an increasing part
of the total amount of Au nanoparticles in the liver was
contained in fewer cells which accumulated in growing
clusters. Therefore our observations of small alterations in
the volume of the cytoplasm of the hepatocytes and an in-
crease in the number or vacuoles in most of the mice may
also suggest ongoing degradation process However, a lon-
ger study period (e.g. one year) and more detailed degrad-
ation analysis will be required to investigate if NPRs are
completely eliminated by liver or in contrast this accumu-
lation results toxic for this organ.
Conclusions
The physicochemical properties of NPRs highlight them
as promising agents for bioapplications including imaging
and selective drug delivery. However, the potential
secondary effects that could be triggered by NPRs follow-
ing in vivo administration require special attention. Before
performing in vivo toxicity experiments in animal models,
the in vitro tests in primary and transformed cells are a
must to avoid unnecessary animal usage in case NPRs
present high cell toxicity and to design properly the in
vivo experiments and the parameters to be tested. More-
over, the effect of NPRs on cellular viability is currently a
hotly debated issue that so far has not been clarified. We
show here that NPR internalization by a panel of mouse
and human transformed and primary cells affect mito-
chondrial function and ROS generation, yet do not com-
promise cell viability as shown by clonogenic assays. Thus,
our data indicate that assessment of the toxic effects of
NPRs in vitro requires of multiparametric analyses of dif-
ferent cell functions before a relevant conclusion could be
reached. Other reports have shown that NPR uptake does
indeed modify mitochondrial function and generates ROS
[22]; however, in some cases these changes compromised
cell viability [22, 55, 56] but not in others [24, 42, 57]. In
these cases the type of NPRs and cells tested may be the
cause of these apparent contradictory findings. Our in
vitro results using transformed and primary cells are com-
mensurate with the in vivo findings, which indicate that
large (150 nm) gold NPRs are non-toxic when adminis-
tered intravenously even after four months; although small
amounts do accumulate in the liver and spleen and could
be associated to small alterations in the liver which never-
theless do not seem to affect the animal health. These are
the first analyses of the in vivo toxic effects including in-
flammatory response of gold NPRs supporting the use of
this type of NPs for in vivo biomedical applications. How-
ever before gold NPRs could be introduced in clinical set-
tings more detailed studies including other toxicity
parameters like a more detailed immunogencity study and
genotoxicity and using different coatings, administration
routes and prolonged study times will be required.
Methods
Synthesis and characterization of the gold NPRs
All chemicals and solvents were of analytical grade pur-
chased from Sigma (Sigma-Aldrich, St. Louis, MO, USA)
and used as supplied, without further purification. Pure
water was used throughout by passing water through a
Milli-Q Academic purification set (Millipore Sigma,
Billerica, MA, USA).
To synthesize NPRs, prior to use, all the glass material
was washed with aqua regia and rinsed thoroughly with
MilliQ water. Then, 100 mL of 2 mM (aq.) HAuCl4 and
120 mL of freshly prepared 0.5 mM Na2S2O3 were
mixed, under mild magnetic stirring conditions for
9 min using c-mag hs stirrer (Ika, Wilmington, NC, USA)
(speed 2 of 5 which corresponds to 500 rpm), prior to a
second addition of 50 mL of 0.5 mM Na2S2O3. This will
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produce gold NPRs of ca. 150 nm (146.2 ± 32.4 nm, cf.
Fig. S1 in the Additional file 1) of length with possessing a
localised surface plasmon resonance (LSPR) band max-
imum in the LSPR in the range at 1050 nm (NIR range)
[7]. These NPRs possess an edge length of ca. 150 nm
and height of 10 nm and were characterized by UV-
Vis spectroscopy and scanning electron microscopy
(Additional file 1: Figure S1) as follows. All samples
were measured in aqueous suspension at room
temperature using a Varian Cary 50 UV-visible spectrom-
eter (Varian, Corona, CA, USA) over the range of 200–
1100 nm in 1 cm quartz cuvettes. Scanning Electron
Microscopy (SEM): a single drop of the aqueous solution
of the NPRs was placed onto a silicon wafer and SEM ana-
lysis were performed using a Inspect F instrument (FEI,
Hilsboro, OR, USA) operated at 30 kV. To increase their
colloidal stability, NPRs were functionalized with poly-
ethylenglycol (PEG) chain (HS-C2H4-CONH-PEG-O-
C3H6-COOH) M.W. 5 kDa, (Rapp-Polymer) and
resuspended in MilliQ water. In general, 1 mg of thiolated
PEG was added to 10 mL of NPRs. Then, the pH of the
solution was raised up to 12.0 using 2 M (aq) NaOH. After
overnight incubation, NPRs were cleaned of the free PEG
by centrifugation (twice for 15 min at 10000 rpm) and the
pellet was resuspended in MilliQ water.
NPRs were derivatised with tetramethylrhodamine–5–
carboxamide cadaverine (5-TAMRA cadaverine); absorp-
tion/emission = 545/576 nm (Anaspec, Fremont, CA,
USA), glucose (4-aminophenyl β-D- glucopyranoside) or
both ligands. 1 mg NPR were incubated with 1 mg of
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydro-
chloride (EDC) and 3 mg of N-hydroxysulfosuccinimide
(Sulfo-NHS) in 1.5 mL of 50 mM 2-(N-morpholino)
ethanesulfonic acid (MES) buffer at pH 6 for 20 min at
37 °C. Activated NPRs were then incubated overnight
with 10 μg of TAMRA (NPR-PT); 40 μg of glucose
(NPR-PG); or a combination of 10 μg of TAMRA and
40 μg of glucose (NPR-PTG). Functionalized NPRs were
then subjected to centrifugal precipitation (twice for
15 min at 10000 rpm) to remove excess reagents and the
pellets were resuspended first in MilliQ water.
NPRs were prepared using endotoxin free water and
filtered in using 0.22 μm syringe cellulose filters in order
to render them sterile. All the experiments were carried
out under sterile conditions working with microbio-
logical class II safety cabinets.
NPRs were characterised by UV-Vis and SEM as previous
described. Zeta potential measurements were done using a
ZetaPALS (Brookhaven, Holtsville, NY, USA). Fluorescence
measurements were performed with a LS 55 Fluorescence
Spectrometer, 120 V (PerkinElmer, Waltham, MA, USA).
Data shown in Additional file 1: Figures. S1-S4.
By using ICP-MS (explained in more detail in animal
section) the Au concentration in the stock was
quantified. The concentration value was used to deter-
mine the extinction coefficient at the maximum of absorb-
ance by plotting the absorbance (at the maximum, LSPR)
versus the concentration of different NPs solutions.
Therefore, the concentration of the stock solutions could
always be estimated by measuring the UV-Vis of the solu-
tions and was always indirectly based in ICP-MS results.
Cell culture
For cell culture the following reactives were used;
DMEM, MEM, RPMI1640, Trypsin-EDTA 0.25% were
purchased from PAN biotech (PAN biotech, Aidenbach,
Germany). Serum (FBS) (Lonza, Basel, Switzerland).
GlutaMAX and pyruvate (Sigma-Aldrich, St. Louis, MO,
USA). Penicillin-Streptomycin, non essential aminoacids
and sodium bicarbonate (Gibco, Gaithersburg, MD, USA).
SV40 transformed mouse embrionary fibroblasts (MEFs)
were kindly provided by Dr. Christoph Borner (Institute of
Molecular Medicine and Cell Research, Centre for Bio-
chemistry and Molecular Research, Freiburg) and mouse
melanoma (B16) and mouse fibrosarcoma (MC57G) were
kindly provided by Markus M Simon (Max-Planck Insti-
tute for Immunobiology, Freiburg). Human cervix carcin-
oma (HeLa), human pancreas carcinoma (MiaPaca) and
human lung carcinoma (A549) were acquired from ATCC
cultures. MEF, B16, HeLa and MiaPaca cells were cultured
in DMEM supplemented with 10% FBS. MC57G cells in
MEM supplemented with 10% FBS. A549 cells in DMEM
supplemented with 10% FBS, 2.2 g/L NaHCO3, 100 mg/L
pyruvate and non-essential amino acids. All of them were
cultured in an incubator at 37 °C with 5% CO2.
Human peripheral-blood mononuclear cells (PBMCs)
were obtained from the blood of 3 healthy donors by
density gradient centrifugation using Ficoll-Paque (GE-
Healthcare, Little Chalfont, UK). Blood samples were
provided by blood and tissue bank of Aragón. This study
has been approved by the Ethics Committee for Clinical
Research of Aragon (CEICA).
Mouse Bone Marrow-derived Macrophages (BMDMs)
were differentiated from bone marrow cells as previously
described [58]. Briefly, cells were obtained from femurs of
3 C57BL10 mice 6–12 weeks of age by flushing the bone
marrow with DMEM and cells were differenciated in
BMDM medium (DMEM supplemented with 10% FBS
and 5% HS both decomplemented, 2 mM GlutaMAX and
10% of L929 cell culture supernatant as a source of
M-CSF) for 6 days. This protocol generates inflammatory
CD11b+CD11c− macrophages with a M1 phenotype as
analysed by its ability to produce IL1β and TNFα in
response to LPS and ATP (data not shown).
Confocal microscopy
2·105 cells were seeded in 24 well plates on 13 mm
diameter cover glasses (105 cells/cm2) (Electron
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microscopy science, Hatfield, PA, USA) overnight to
allow attachment and treated with 0, 25, 50, 100 and
200 μg/mL NPR-PT and NPR-PTG for 24 h in 1 mL,
final volumen. Cells on coverslips were washed with PBS
and fixed with 4% paraformaldehyde solution in PBS for
20 min at 4 °C. Fixed cells were mounted on a drop of
fluoromount-G (SouthernBiotech, Birmingham, AL, USA)
containing 2 μg/mL Hoechst 33,342 (Invitrogen, Carlsbad,
USA). Afterward, the cells were analyzed by confocal mi-
croscopy (60× objective). Fluorescence images were taken
at room temperature on a confocal microscope (Olympus
FV10-i Oil Type) using the same settings for all the cell
lines. The software FV10i-SW was used for minor adjust-
ments to background and image overlay.
Analysis of pro-apoptotic processes by flow cytometry
Cells (2·105 cel/mL) were resuspended in culture
medium, seeded at a 105 cells/cm2 and treated with the
NPRs at different concentrations 0, 25, 50, 100 y 200 μg/
mL for 48 h at 37 °C and 5% CO2 and the different
apoptotic parameters were tested by flow cytometry with
a FACS Calibur (BD, Franklin Lakes, NJ, United States)
and CellQuests software. ROS generation was analysed
using dihydroethidine (2HE, 2 μM) (Invitrogen,
Carlsbad, USA), Δψm was measured with the fluorescent
probe 3,3-dihexyloxacarbocyanine iodide (DiOC6) 10 nM
(Invitrogen, Carlsbad, USA) and PS exposure and 7AAD
uptake was analyzed using annexinV–DY634 and 7AAD
at 1/100 dilution (Inmunostep, Salamanca, Spain), as fol-
lows. Briefly, cells were tripsinyzed, centrifugated 300 xg
for 5 min and incubated with the probe for 20 min at
room temperature, in cell culture medium for 2HE and
DiOC6(3) or in annexin binding buffer (Inmunostep,
Salamanca, Spain) for annexin V. [58].
Clonogenic survival assay
Clonogenic assay or colony formation assay is an in vitro
cell survival assay based on the ability of a single cell to
grow and generate a colony. 48 h after treatment, cells
were trypsinized and 100 cells were seeded per well in a
final volume of 3 mL in a six-well plate (10 cells/cm2).
Cells were allowed to grow during 10 days and after that
time, medium was removed and cell colonies were
counted after fixing and colouring them for 20 min with
a mixture of glutaraldehyde (6.0% v/v) and crystal violet
(0.5% w/v) at room temperature.
Animal experimentation
All the experiments involving animals were made according
to the law RD53/2013 and approved by the Ethics Commit-
tee for Animal Research from University of Zaragoza that is
an accreditated animal-welfare body. All the experiments
were performed according to the institutional animal use
and care regulation of the Centro de Investigación
Biomédica de Aragón (CIBA; Zaragoza, Spain). The ani-
mals were purchased from the CIBA centre and fed a
standard diet ad libitum throughout the experiments.
Pathogen-free 6 week old Swiss mice were randomly di-
vided into 2 different groups: mice injected with NPR-PTG
and control group where PBS was injected. To reach statis-
tically significant results, 2 independent experiments were
performed. Each group (control and treated) consisted of
10 animals, 5 male and 5 female, in order to discard sexual-
biased results. NPR-PTG were suspended in 100 μL of PBS
and injected intravenously in the tail vein at dose of 6 μg
NPR-PTG per g. This dose corresponds to approximately
75–100 μg NPR-PTG/mL blood in the moment of adminis-
tration, which is in accordance with the concentrations ana-
lysed in the experiments in vitro. Mice were sacrificed 72 h
and 4 months after the injection in CO2 gas chamber. Sub-
sequently the blood has been collected by cardiac puncture
using 10% of sodium citrate as anticoagulant for plasma
separation via centrifugation (15 min, 2000 x g). ALT (ala-
nine aminotransferase), and CK (creatine kinase), activities
was measured according to the IFCC recommendations,
by means of the decrease (ALT) or increase (CK) of ab-
sorbance at 340 nm. Determination of LDH (lactate de-
hydrogenase) activity was measured by the transformation
of lactate to piruvate, measuring the increase of absorb-
ance at 340 nm. Creatinine concentrations were deter-
mined by the Jaffé method. All measurements were
carried out using an automated analyzer Cobas c501
(Roche Diagnostics, Indianapolis, IN, USA).
Levels of IFNγ and TNFα were quantified with their re-
spective “Ready-Set-Go” ELISA kit (eBioscience, San Diego,
CA USA) following manufacturer’s instructions for which
100 μL serum were needed per each cytokine analyzed in a
96 well plate format. The detection method is based on the
enzyme Pre-titrated Avidin HRP (horseradish peroxidase)
measuring absorbance at 450 nm and 570 nm in a plate
reader Synergy ™ HT (BioTek, Winooski, VT, USA). The re-
sults were obtained substrating the values of 570 from
those of 450 (Abs 450-Abs 570).
Finally liver, spleen, kidneys, heart, lungs, thymus and
reproductive organs were excised and prepared for,
histopathological tissue examination, TEM, STEM and
ICP-MS measurements. In the case of short term study
(72 h) three mice from NPR-PTG group and one from
control were placed in a metabolic cage enabling urine
samples collection every 24 h.
Histology examination of haematoxylin and eosin stained
tissue sections
For pathological examination of the organs, pieces of the
excised organs were fixed with pH 7.4 phosphate-buffered
4% paraformaldehyde during 24 h at 4 °C and processed
in mesh cassettes (Mesh Biopsy Cassette) using a standard
protocol in an automatic tissue processor; Tissue-Tek
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Xpress ×50 (Sakura Fineteck, Torrance, CA, USA). The
preparation of the blocks was carried out with the block
making unit Leica EG1150 (Leica Bioscience, Wetzlar,
Germany) after which the blocks were solidified on a cold
plate. Samples were embedded in paraffin, sectioned at
3 μm thick (Rotary microtome Leica RM2255) and placed
in a tempered bath where they were collected with Super-
frost slides (Dako Flex IHC Microscope Slides; ref.:
K8020) (Angilent technologies, Santa Clara, CA, USA).
The slides were placed in vertical racks and allowed to dry
in an oven. After dewaxing and hydration process, the
samples were stained with hematoxylin and eosin ready-to-
use Dako (Agilent, Santa Clara, CA, USA) and mounted
with permanent mounting medium DPX.
TEM and STEM characterization of organs
For electron microscopic analysis, the excised organs
were cut into 1 mm3 pieces and fixed with 2.5% glutaral-
dehyde/2% paraformaldehyde in 0.1 M sodium phos-
phate buffer at pH 7.4 for 24 h at room temperature and
subsequently stored for 5 days at 4 °C. Thereafter the
samples were washed for 30 min four times with sodium
phosphate buffer, post-fixed with 2% osmium, rinsed,
dehydrated and embedded in Durcupan resin Fluka
(Sigma-Aldrich, St. Louis, MO, USA). Semithin sections
(1.5 μm) were cut with an Ultracut UC-6 (Leica,
Wetzlar, Germany) and stained lightly with 1% toluidine
blue. Finally, ultra-thin sections (0.08 μm) were cut with
a diamond knife, stained with lead citrate (Reynolds so-
lution) and examined under a 300 kV transmission elec-
tron microscope FEI Tecnai F30 enabling working in
STEM mode and performing X-Ray Microanalysis (EDS)
(FEI Europe, Eindhoven, The Netherlands).
ICP-MS
Organs were washed in PBS buffer and frozen in liquid
nitrogen upon collection. Following, they were thawed
and washed trice in distillate water. All samples were ly-
ophilized using Laboratory Freeze Dryer CRYODOS
(Telstar Industrial, S.L., Terrassa, Spain), weighted,
placed in porcelain crucibles and burned in a Mini Muf-
fle Furnace (Nabertherm GmbH, Lilienthal, Germany) at
600 °C during 45 min. To the cooled ashes 200 μL of pi-
ranha solution (>85% sulphuric acid and > 50% hydro-
gen peroxide) were added and the solution was left for
10 min. Following, 200 μL of aqua regia was added, the
solution was transferred to a 15 mL centrifuge tube
(TPP Techno Plastic Products AG, Trasadingen,
Switzerland) and heated at 70 °C for one hour using a
thermoblock (Thermo Fisher, Massachusetts, USA). For
ICP analysis, the content of acids has to be between 1
and 5%. Therefore, the samples were centrifuged for
5 min to eliminate the ashes, trasfered to a 50 mL cen-
trifuge tube (TPP Techno Plastic Products AG,
Trasadingen, Switzerland) and diluted to the final vol-
ume of 20 mL (2% of acids) using graduated cylinder.
The quantitative Au analysis was performed by using
ICP-MS 7700× (Agilent Technologies, Sta Clara, CA,
USA). ICP-MS was used for Au determination using a
MicroMist micro-uptake glass concentric nebulizer
(Glass Expansion, West Melbourne, Victoria, Australia).
In order to reduce MO+ formation in the plasma, the
spray chamber was peltier cooled at 2 °C. A standard
quartz torch with 2.5 mm internal diameter injector was
used. Finally, standard nickel cones (sample and skimmer)
were used. The optimization of the ICP-MS conditions
was achieved by adjusting the torch position and tuning
for reducing oxide and doubly charged ion formation with
a standard tuning solution containing 1.0 μg L−1 of 7Li,
24Mg, 59Co, 89Y, 140Ce and 205Tl in 1.0% HNO3. This
equipment includes a collision cell (He gas, ORS3 system,
Agilent Technologies ©) for discriminate spectral interfer-
ences with high performance for all the trace metals con-
sidered in here. The calibration curve comprises a linear
range from 0.01 to 20 ppb.
The precision of the analysis is < 10%. Other parame-
ters such as accuracy and recovery could not be deter-
mined without knowing the exact Au content in the
sample before measuring it.
All the analysis were performed in the Servicio Central
Analisis de Bizkaia (Universidad del Pais Vasco).
Statistical analysis
All data are presented as the mean ± standard deviation
(SD). Significant differences between groups were evalu-
ated by two-way ANOVA with Bonferroni post-test
using GraphPad Prism 5.0 (GraphPad 339 Software, CA,
USA). * p < 0.05, **p < 0.01, ***p < 0.001.
Additional file
Additional file 1: Figure S1. a) SEM micrograph of the initial NPR-P. b)
Length (L) distribution of the NPRs, average length is 146.2 ± 32.4 nm. c)
UV/Vis spectra of a NPR-P solution. Figure S2. a) Agarose gel (0.7%, 100 V,
1 h) of the pegylated NPRs (NPR-P) and the modified ones (NPR-PT, NPR-
PTG and NPR-PG). b) ζ-potential measurements of the final NPRs measured
in water and using a concentration of 0.04 mg/mL. Figure S3. Fluorescence
spectra of NPRs solutions labeled with TAMRA. In black, there is the
normalized spectrum for NPR-PT, and in red the normalized spectra
for NPR-PTG. Figure S4. UV/Vis spectra of NPRs before (red) and after
(black) their incubation in complete cell media during 24 h. Figure S5. (A)
Analysis of cell morphology changes by flow cytometry. MiaPaca, HeLa,
A549, MEF, B16, MC57G line cells were incubated with four types of
nanoparticles (NPR-P, NPR-PG, NPR-PT, NPR-PTG) at four concentrations (25,
50, 100 and 200 μg/mL) for 48 h as indicated in experimental section. After
incubation time, cells were analyzed by flow cytometry. A representative
experiment is shown at the concentration of 200 μg/mL Note: Ctrl = negative
control. Figure S6. Periodic acid-Schiff (PAS) and periodic acid-Schiff diastasa
(PAS/D) stain of the liver of mice treated with NPRs. Mice were injected (i.v)
with 6 μg/g NPR-PTG and sacrificed after 4 months, the organs were fixed
and processed for PAS staining, as indicated in experimental section.
Representative images are shown. (DOCX 45107 kb)
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